Overcome the unpredictability of infectious diseases.
您需要成功的经验和敏捷性
A host of new and re-emerging pathogens. An increasingly diverse and dynamic research environment. The study of infectious disease and vaccines is as complex as the populations and environments they impact.
为了具有竞争力，为了通过敏捷性和可靠的方法的适当平衡来应对这种环境，在每个开发阶段都量身定制的解决方案至关重要。
At IQVIA, we have specialized teams of research professionals and board-certified physicians that are trained in customized solutions for companies of every size and at every stage, as well as for government and nonprofit organizations working to advance broader public health goals.
专家支持您最艰难的挑战
- Fast-paced vaccine and seasonal research from first-in-human trials through late-phase
- Medical management of complex, global, regional and seasonal clinical trials
- 疾病领域的专业知识知识和热带疾病，HIV，疟疾，结核病和新兴病原体（例如埃博拉病毒和LASSA病毒）
- 特定于传染病的监管支持，包括生物制剂，转基因生物和细胞以及基因疗法
- Collaborations with Biomedical Advanced Research and Development Authority (BARDA) and government funded trials
- Experience in adaptive designs and new site technologies
The power to protect global health with the IQVIA CORE™
传染病治疗的发展没有不确定性的余地。保护全球健康需要由数据驱动的见解所告必威手机APP知的策略，并由经验丰富的团队和熟练资源网络自信地执行计划。betway必威怎么提款通过整合无与伦比的数据，高级分析和适合用途的机器学习，IQVIA提供了创新的方法来帮助您管理风险并找到正确的成功途径。
从研究到商业化，这一切都由IQVIA Core提供动力，这是一种整体方法，它整合了我们的资源来应对传染病的挑战。手机版必威
Public Health and Government
Use big data and predictive analytics to improve human health.
通过IQVIA Core™的功能提高临床试验的性能。手机版必威
全面的实验室解决方案，适合适合。
Access new resources for advanced therapy development, from candidate identification through market authorization.